Paper41514979
Cyanobacterial Biofactories Beyond Model Strains: Exploratory Screening of Immunomodulatory Activity in Phormidium ambiguum Extracts.
Sandybayeva SK and 4 others. Plants (Basel), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Cyanobacterial Biofactories Beyond Model Strains: Exploratory Screening of Immunomodulatory Activity in Phormidium ambiguum Extracts. Papers, record 41514979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41514979
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cyanobacterial Biofactories Beyond Model Strains: Exploratory Screening of Immunomodulatory Activity in Phormidium ambiguum Extracts.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AP22685516 | The Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32035961 | A thermophilic C-phycocyanin with unprecedented biophysical and biochemical properties. | Int J Biol Macromol | 2020 | https://conductscience.org/library/papers/32035961 | PubMed |
| 2 | 21468079 | Cyanobacteria: an emerging source for drug discovery. | J Antibiot (Tokyo) | 2011 | https://conductscience.org/library/papers/21468079 | PubMed |
| 3 | 33284578 | Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics. | ACS Chem Neurosci | 2020 | https://conductscience.org/library/papers/33284578 | PubMed |
| 4 | 39639093 | Immunomodulatory properties of polysaccharide extract samples from Cyanobacterium sp. Rippka B-1200. | Sci Rep | 2024 | https://conductscience.org/library/papers/39639093 | PubMed |
| 5 | 29403965 | Methods for in vitro evaluating antimicrobial activity: A review. | J Pharm Anal | 2016 | https://conductscience.org/library/papers/29403965 | PubMed |
| 6 | 11421730 | Somamides A and B, two new depsipeptide analogues of dolastatin 13 from a Fijian cyanobacterial assemblage of Lyngbya majuscula and Schizothrix species. | J Nat Prod | 2001 | https://conductscience.org/library/papers/11421730 | PubMed |
| 7 | 40063398 | Characterization of Bioactive Metabolites in Phormidium sp. PB21: Pigment Production, Antimicrobial Potential, and Toxicity Assessment. | Chem Biodivers | 2025 | https://conductscience.org/library/papers/40063398 | PubMed |
| 8 | 35456747 | Cyanobacteria: Model Microorganisms and Beyond. | Microorganisms | 2022 | https://conductscience.org/library/papers/35456747 | PubMed |
| 9 | 26904724 | New Medium for Pharmaceutical Grade Arthrospira. | Int J Bacteriol | 2013 | https://conductscience.org/library/papers/26904724 | PubMed |
| 10 | 31887317 | Portoamides A and B are mitochondrial toxins and induce cytotoxicity on the proliferative cell layer of in vitro microtumours. | Toxicon | 2020 | https://conductscience.org/library/papers/31887317 | PubMed |
| 11 | 37112036 | Phormidium ambiguum and Leptolyngbya ohadii Exopolysaccharides under Low Water Availability. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37112036 | PubMed |
| 12 | 19393308 | Biotechnological and industrial significance of cyanobacterial secondary metabolites. | Biotechnol Adv | 2009 | https://conductscience.org/library/papers/19393308 | PubMed |
| 13 | 9887530 | Hierridin B and 2,4-dimethoxy-6-heptadecyl-phenol, secondary metabolites from the cyanobacterium Phormidium ectocarpi with antiplasmodial activity. | Phytochemistry | 1998 | https://conductscience.org/library/papers/9887530 | PubMed |
| 14 | 33036172 | The Chemistry, Biochemistry and Pharmacology of Marine Natural Products from Leptolyngbya, a Chemically Endowed Genus of Cyanobacteria. | Mar Drugs | 2020 | https://conductscience.org/library/papers/33036172 | PubMed |
| 15 | 39519869 | Isolation, Identification and Pigment Analysis of Novel Cyanobacterial Strains from Thermal Springs. | Plants (Basel) | 2024 | https://conductscience.org/library/papers/39519869 | PubMed |
| 16 | 32098255 | Carotenoids from Cyanobacteria: A Biotechnological Approach for the Topical Treatment of Psoriasis. | Microorganisms | 2020 | https://conductscience.org/library/papers/32098255 | PubMed |
| 17 | 28073542 | The rise of toxic benthic Phormidium proliferations: A review of their taxonomy, distribution, toxin content and factors regulating prevalence and increased severity. | Harmful Algae | 2016 | https://conductscience.org/library/papers/28073542 | PubMed |
| 18 | 36046667 | The survivor strain: isolation and characterization of Phormidium yuhuli AB48, a filamentous phototactic cyanobacterium with biotechnological potential. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36046667 | PubMed |
| 19 | 36836671 | Physiological and Biochemical Responses in Microalgae Dunaliella salina, Cylindrotheca closterium and Phormidium versicolor NCC466 Exposed to High Salinity and Irradiation. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36836671 | PubMed |
| 20 | 35265106 | Biosynthesis and Characterization of Silver Nanoparticles Produced by Phormidium ambiguum and Desertifilum tharense Cyanobacteria. | Bioinorg Chem Appl | 2022 | https://conductscience.org/library/papers/35265106 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42635640 | Development of a Marine Algae-based Facial Cream Enriched With Phycoerythrin: Physicochemical Properties and Biological Activities. | Mar Biotechnol (NY) | 2026 | https://conductscience.org/library/papers/42635640 | PubMed |
| 41681662 | High-Purity Isolation of Polyphosphate-Rich Stabilisomes Defines Their Conserved Chemical Architecture in Thermophilic Cyanobacteria. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/41681662 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41514979
GET https://conductscience.org/api/papers/v1/41514979/references?page=2